Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 18 Show results per page	View Search Criteria \| Help With Results

Last Modified: 5/28/2008 First Published: 10/1/2000


1.		Phase III Randomized Study of Ondansetron in Patients With Advanced Cancer and Chronic Nausea and Emesis Not Due to Antineoplastic Therapy

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Completed				Not specified				NCI				NCCTG-989201 NCI-P00-0168, NCT00006348

Last Modified: 4/20/2007 First Published: 5/1/2001


2.		Phase III Randomized Study of Ondansetron With or Without Dexamethasone as Prophylaxis for Radiation-Induced Emesis in Patients Receiving Upper Abdominal Radiotherapy

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Closed				16 and over				Other				CAN-NCIC-SC19 NCT00016380, SC19

Last Modified: 12/4/2006 First Published: 7/1/2001


3.		Phase III Randomized Study of 3 Regimens For the Prevention of Delayed Nausea After Chemotherapy in Patients With Chemotherapy-Naive Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Completed				18 and over				NCI				URCC-U3901 NCI-P01-0180, NCT00020657

Last Modified: 3/1/1992


4.		Phase III Study of Ondansetron vs Droperidol for the Treatment of Immunotherapy-Induced Emesis (Summary Last Modified 03/92)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Completed				18 and over				NCI				NCI-92-C-0043 NCI-T91-0277N, T91-0277

Last Modified: 5/31/2007 First Published: 8/1/1999


5.		Phase II Randomized Study of Acupressure and Acustimulation Wrist Bands for the Prevention of Chemotherapy Induced Nausea and Vomiting

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Supportive care				Closed				18 and over				Other				URCC-U3997 NCI-V99-1528, NCT00003817

Last Modified: 12/1/1995


6.		Phase II Study of CDDP/CBDCA with Ondansetron or Granisetron and G-CSF in Patients with Stage III/IV Epithelial Ovarian Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Supportive care, Treatment				Closed				no age specified				Other				NBSG-9204 NCI-V92-0153

Last Modified: 11/8/2006


7.		Phase II Study of CDDP/CTX/DOX with G-CSF and Ondansetron in Patients with Metastatic or Recurrent Adenocarcinoma of the Endometrium

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Supportive care, Treatment				Closed				18 and over				Other				NBSG-9206 NCI-V92-0158

Last Modified: 12/1/1993


8.		Phase II Study of Single-Dose Intravenous Ondansetron/Dexamethasone to Control Acute Vomiting Followed by Oral Dexamethasone/Prochlorperazine to Control Delayed Vomiting in Patients Receiving High-Dose Doxorubicin (Summary Last Modified 12/93)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Supportive care				Completed				18 and over								MSKCC-93098 NCI-V93-0318


9.		Comparison of Delta-8-THC to Ondansetron in the Prevention of Acute Nausea From Moderately Emetogenic Chemotherapy

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Supportive care				Temporarily closed				18 to 85				Pharmaceutical / Industry				Rafa protocol THC002/NVP NCT00285051

Last Modified: 11/8/2006 First Published: 7/1/2000


10.		Randomized Study of the Efficacy of Patient Information in Alleviating Nausea and Emesis in Cancer Patients Receiving Chemotherapy (Summary Last Modified 01/2001)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Educational/Counseling/Training				Closed				18 and over				NCI				URCC-3996 NCI-P00-0160, NCT00005994

Select All on One Page


					1 2 Next >

| | | | | | | |

A Service of the National Cancer Institute